Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-15
2000-02-08
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514320, 514321, A61K 31445
Patent
active
060228792
ABSTRACT:
The present invention provides a method of treating amyotrophic lateral sclerosis and other neurologic diseases by administering bathocuproine or a related analog. Also provided are pharmaceutical compositions of bathocuproine.
REFERENCES:
patent: 5834457 (1998-11-01), Bredesen et al.
Ghadge et al., "Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis:molecular mechanisms of neuronal death and protection", J. Neurosci. (1997), 17(22), pp. 8756-8766 (abstract).
Beckman Joseph S.
Crow John P.
Adler Benjamin Aaron
UAB Research Foundation
Weddington Kevin E.
LandOfFree
Bathocuproine treatment of neurologic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bathocuproine treatment of neurologic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bathocuproine treatment of neurologic disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681669